NMDA receptor subtypes: Structure, function and therapeutics

Current Anaesthesia and Critical Care

Volumn 19, Issue 4, 2008, Pages 183-201

  Chaffey, Heather ^a   Chazot, Paul L ^a  

^a DURHAM UNIVERSITY   (United Kingdom)

Author keywords

Analgesia; Memantine; Neuroprotection; NMDA; NR2B; Subtypes

Indexed keywords

4 PHOSPHONOMETHYLPIPECOLIC ACID; 6,7 DICHLORO 5 NITRO 2,3 QUINOXALINEDIONE; DIZOCILPINE; ELIPRODIL; GLUTAMATE RECEPTOR; HALOPERIDOL; IFENPRODIL; IONOTROPIC RECEPTOR; KETAMINE; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2C; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2D; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 3; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 3A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 3B; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; PHENCYCLIDINE; RO 04 5595; RO 256981; TRAXOPRODIL;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BINDING SITE; BRAIN INJURY; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM; CHRONIC PAIN; CLINICAL TRIAL; COGNITION; DEMENTIA; DRUG BINDING; DRUG STRUCTURE; EXCITOTOXICITY; HUMAN; HUNTINGTON CHOREA; MAMMAL; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TARGETING; SCHIZOPHRENIA; SENSITIZATION; SPINAL CORD; STROKE; UNSPECIFIED SIDE EFFECT;

EID: 48749130638     PISSN: 09537112     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cacc.2008.05.004     Document Type: Article

References (167)

1. Verkhratsky A., and Kirchhoff F. NMDA receptors in glia. Neuroscientist 13 1 (2007) 28-37
2. Kew J.N., and Kemp J.A. Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology (Berlin) 179 1 (2005) 4-29 Erratum in: Psychopharmacology (Berlin) 2005 October;182(2):320
3. Stephenson F.A. Subunit characterization of NMDA receptors. Curr Drug Targets 2 3 (2001) 233-239
4. Chazot P.L. The NMDA receptor NR2B subunit: a valid therapeutic target for multiple CNS pathologies. Curr Med Chem 11 3 (2004) 389-396
5. Moriyoshi K., Masu M., Ishii T., Shigemoto R., Mizuno N., and Nakanishi S. Molecular cloning and characterization of the rat NMDA receptor. Nature 354 6348 (1991) 31-37
6. Kutsuwada T., Kashiwabuchi N., Mori H., Sakimura K., Kushiya E., Araki K., et al. Molecular diversity of the NMDA receptor channel. Nature 358 6381 (1992) 36-41
7. Monyer H., Burnashev N., Laurie D.J., Sakmann B., and Seeburg P.H. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12 3 (1994) 529-540
8. Ishii T., Moriyoshi K., Sugihara H., Sakurada K., Kadotani H., Yokoi M., et al. Molecular characterization of the family of the N-methyl-d-aspartate receptor subunits. J Biol Chem 268 4 (1993) 2836-2843
9. Ciabarra A.M., Sullivan J.M., Gahn L.G., Pecht G., Heinemann S., and Sevarino K.A. Cloning and characterization of chi-1: a developmentally regulated member of a novel class of the ionotropic glutamate receptor family. J Neurosci 15 10 (1995) 6498-6508
10. Sucher N.J., Akbarian S., Chi C.L., Leclerc C.L., Awobuluyi M., Deitcher D.L., et al. Developmental and regional expression pattern of a novel NMDA receptor-like subunit (NMDAR-L) in the rodent brain. J Neurosci 15 10 (1995) 6509-6520
11. Nishi M., Hinds H., Lu H.P., Kawata M., and Hayashi Y. Motoneuron-specific expression of NR3B, a novel NMDA-type glutamate receptor subunit that works in a dominant-negative manner. J Neurosci 21 23 (2001) RC185
12. Matsuda K., Kamiya Y., Matsuda S., and Yuzaki M. Cloning and characterization of a novel NMDA receptor subunit NR3B: a dominant subunit that reduces calcium permeability. Brain Res Mol Brain Res 100 1-2 (2002) 43-52
13. Dingledine R., Borges K., Bowie D., and Traynelis S.F. The glutamate receptor ion channels. Pharmacol Rev 51 1 (1999) 7-61
14. Armstrong N., Sun Y., Chen G.Q., and Gouaux E. Structure of a glutamate-receptor ligand-binding core in complex with kainate. Nature 395 6705 (1998) 913-917
15. Cull-Candy S., Brickley S., and Farrant M. NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol 11 3 (2001) 327-335
16. Blahos II J., and Wenthold R.J. Relationship between N-methyl-d-aspartate receptor NR1 splice variants and NR2 subunits. J Biol Chem 271 26 (1996) 15669-15674
17. Chazot P.L., and Stephenson F.A. Biochemical evidence for the existence of a pool of unassembled C2 exon-containing NR1 subunits of the mammalian forebrain NMDA receptor. J Neurochem 68 2 (1997) 507-516
18. Standley S., Roche K.W., McCallum J., Sans N., and Wenthold R.J. PDZ domain suppression of an ER retention signal in NMDA receptor NR1 splice variants. Neuron 28 3 (2000) 887-898
19. Köpke A.K., Bonk I., Sydow S., Menke H., and Spiess J. Characterization of the NR1, NR2A, and NR2C receptor proteins. Protein Sci 2 12 (1993) 2066-2076
20. McBain C.J., and Mayer M.L. N-methyl-d-aspartic acid receptor structure and function. Physiol Rev 74 3 (1994) 723-760
21. Akesson E., Kjaeldgaard A., Samuelsson E.B., Seiger A., and Sundström E. Ionotropic glutamate receptor expression in human spinal cord during first trimester development. Brain Res Dev Brain Res 119 1 (2000) 55-63
22. Wenthold R.J., Yokotani N., Doi K., and Wada K. Immunochemical characterization of the non-NMDA glutamate receptor using subunit-specific antibodies. Evidence for a hetero-oligomeric structure in rat brain. J Biol Chem 267 1 (1992) 501-507
23. Brose N., Gasic G.P., Vetter D.E., Sullivan J.M., and Heinemann S.F. Protein chemical characterization and immunocytochemical localization of the NMDA receptor subunit NMDA R1. J Biol Chem 268 30 (1993) 22663-22671
24. Chazot P.L., Coleman S.K., Cik M., and Stephenson F.A. Molecular characterization of N-methyl-d-aspartate receptors expressed in mammalian cells yields evidence for the coexistence of three subunit types within a discrete receptor molecule. J Biol Chem 269 39 (1994) 24403-24409
25. Suchanek B., Seeburg P.H., and Sprengel R. Gene structure of the murine N-methyl d-aspartate receptor subunit NR2C. J Biol Chem 270 1 (1995) 41-44
26. Yao Y., and Mayer M.L. Characterization of a soluble ligand binding domain of the NMDA receptor regulatory subunit NR3A. J Neurosci 26 17 (2006) 4559-4566
27. Andersson O., Stenqvist A., Attersand A., and von Euler G. Nucleotide sequence, genomic organization, and chromosomal localization of genes encoding the human NMDA receptor subunits NR3A and NR3B. Genomics 78 3 (2001) 178-184
28. Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomeli H., et al. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256 5060 (1992) 1217-1221
29. Takai H., Katayama K., Uetsuka K., Nakayama H., and Doi K. Distribution of N-methyl-d-aspartate receptors (NMDARs) in the developing rat brain. Exp Mol Pathol 75 1 (2003) 89-94
30. Wenzel A., Villa M., Mohler H., and Benke D. Developmental and regional expression of NMDA receptor subtypes containing the NR2D subunit in rat brain. J Neurochem 66 3 (1996) 1240-1248
31. Wang Y.H., Bosy T.Z., Yasuda R.P., Grayson D.R., Vicini S., Pizzorusso T., et al. Characterization of NMDA receptor subunit-specific antibodies: distribution of NR2A and NR2B receptor subunits in rat brain and ontogenic profile in the cerebellum. J Neurochem 65 1 (1995) 176-183
32. Nagy G.G., Watanabe M., Fukaya M., and Todd A.J. Synaptic distribution of the NR1, NR2A and NR2B subunits of the N-methyl-d-aspartate receptor in the rat lumbar spinal cord revealed with an antigen-unmasking technique. Eur J Neurosci 20 12 (2004) 3301-3312
33. Sundström E., Whittemore S., Mo L.L., and Seiger A. Analysis of NMDA receptors in the human spinal cord. Exp Neurol 148 2 (1997) 407-413
34. Loftis J.M., and Janowsky A. The N-methyl-d-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications. Pharmacol Ther 97 1 (2003) 55-85
35. Laurie D.J., Bartke I., Schoepfer R., Naujoks K., and Seeburg P.H. Regional, developmental and interspecies expression of the four NMDAR2 subunits, examined using monoclonal antibodies. Brain Res Mol Brain Res 51 1-2 (1997) 23-32
36. Mutel V., Buchy D., Klingelschmidt A., Messer J., Bleuel Z., Kemp J.A., et al. In vitro binding properties in rat brain of [3H]Ro 25-6981, a potent and selective antagonist of NMDA receptors containing NR2B subunits. J Neurochem 70 5 (1998) 2147-2155
37. Rigby M., Heavens R.P., Smith D., O'Donnell R., Hill R.G., and Sirinathsinghji D.J.S. Distribution of NMDA receptors in brain and spinal cord. In: Sirinathsinghji D.J.S., and Hill R.G. (Eds). NMDA antagonists as potential analgesic drugs (2002), Birkhauser, Basel 45-65
38. Tölle T.R., Berthele A., Zieglgänsberger W., Seeburg P.H., and Wisden W. The differential expression of 16 NMDA and non-NMDA receptor subunits in the rat spinal cord and in periaqueductal gray. J Neurosci 13 12 (1993) 5009-5028
39. Wenzel A., Villa M., Mohler H., and Benke D. Developmental and regional expression of NMDA receptor subtypes containing the NR2D subunit in rat brain. J Neurochem 66 3 (1996) 1240-1248
40. Jones E.G., Tighilet B., Tran B.V., and Huntsman M.M. Nucleus- and cell-specific expression of NMDA and non-NMDA receptor subunits in monkey thalamus. J Comp Neurol 397 3 (1998) 371-393
41. Scherzer C.R., Landwehrmeyer G.B., Kerner J.A., Counihan T.J., Kosinski C.M., Standaert D.G., et al. Expression of N-methyl-d-aspartate receptor subunit mRNAs in the human brain: hippocampus and cortex. J Comp Neurol 390 1 (1998) 75-90
42. Watanabe M., Mishina M., and Inoue Y. Distinct spatiotemporal distributions of the N-methyl-d-aspartate receptor channel subunit mRNAs in the mouse cervical cord. J Comp Neurol 345 2 (1994) 314-319
43. Thompson C.L., Drewery D.L., Atkins H.D., Stephenson F.A., and Chazot P.L. Immunohistochemical localization of N-methyl-d-aspartate receptor subunits in the adult murine hippocampal formation: evidence for a unique role of the NR2D subunit. Brain Res Mol Brain Res 102 1-2 (2002) 55-61
44. Al-Hallaq R.A., Jarabek B.R., Fu Z., Vicini S., Wolfe B.B., and Yasuda R.P. Association of NR3A with the N-methyl-d-aspartate receptor NR1 and NR2 subunits. Mol Pharmacol 62 5 (2002) 1119-1127
45. Fukaya M, Watanabe M. Selective localization of NR3A subunit at climbing fiber-interneuron synapses in the cerebellum, Society for neuroscience Abstract, 2007.
46. Eriksson M., Nilsson A., Froelich-Fabre S., Akesson E., Dunker J., Seiger A., et al. Cloning and expression of the human N-methyl-d-aspartate receptor subunit NR3A. Neurosci Lett 321 3 (2002) 177-181 Erratum in: Neurosci Lett 2002 October 4;331(1):69-70
47. Fukaya M., Hayashi Y., and Watanabe M. NR2 to NR3B subunit switchover of NMDA receptors in early postnatal motoneurons. Eur J Neurosci 21 5 (2005) 1432-1436
48. Matsuda K., Fletcher M., Kamiya Y., and Yuzaki M. Specific assembly with the NMDA receptor 3B subunit controls surface expression and calcium permeability of NMDA receptors. J Neurosci 23 31 (2003) 10064-10073
49. Clark B.A., and Cull-Candy S.G. Activity-dependent recruitment of extrasynaptic NMDA receptor activation at an AMPA receptor-only synapse. J Neurosci 22 11 (2002) 4428-4436
50. Wee KSL, Zhang Y, Khanna S, Low CM. Immunolocalisation of NR3B subunit of the N-methyl-d-aspartate receptor in the adult rat central nervous system, SfN Abstract, November 2007.
51. Luo J., Wang Y., Yasuda R.P., Dunah A.W., and Wolfe B.B. The majority of N-methyl-d-aspartate receptor complexes in adult rat cerebral cortex contain at least three different subunits (NR1/NR2A/NR2B). Mol Pharmacol 51 1 (1997) 79-86
52. Dunah A.W., Luo J., Wang Y.H., Yasuda R.P., and Wolfe B.B. Subunit composition of N-methyl-d-aspartate receptors in the central nervous system that contain the NR2D subunit. Mol Pharmacol 53 3 (1998) 429-437
53. Wyllie D.J., Béhé P., and Colquhoun D. Single-channel activations and concentration jumps: comparison of recombinant NR1a/NR2A and NR1a/NR2D NMDA receptors. J Physiol 510 Pt 1 (1998) 1-18 Erratum in: J Physiol (London) 1998 November 1;512(Pt 3):939
54. Nowak L.M., and Wright J.M. Slow voltage-dependent changes in channel open-state probability underlie hysteresis of NMDA responses in Mg(2+)-free solutions. Neuron 8 1 (1992) 181-187
55. Williams J.M., Mason-Parker S.E., Abraham W.C., and Tate W.P. Biphasic changes in the levels of N-methyl-d-aspartate receptor-2 subunits correlate with the induction and persistence of long-term potentiation. Brain Res Mol Brain Res 60 1 (1998) 21-27
56. Williams K. Modulation and block of ion channels: a new biology of polyamines. Cell Signal 9 1 (1997) 1-13
57. Qian A., and Johnson J.W. Permeant ion effects on external Mg2+ block of NR1/2D NMDA receptors. J Neurosci 26 42 (2006) 10899-10910
58. Antonov S.M., and Johnson J.W. Permeant ion regulation of N-methyl-d-aspartate receptor channel block by Mg(2+). Proc Natl Acad Sci USA 96 25 (1999) 14571-14576
59. Hori N., and Carpenter D.O. Transient ischemia causes a reduction of Mg2+ blockade of NMDA receptors. Neurosci Lett 173 1-2 (1994) 75-78
60. Zhang L., Rzigalinski B.A., Ellis E.F., and Satin L.S. Reduction of voltage-dependent Mg2+ blockade of NMDA current in mechanically injured neurons. Science 274 5294 (1996) 1921-1923
61. Zigmond M.J., et al. Fundamental neuroscience (1995), Academic Press, San Diego
62. Prybylowski K., and Wenthold R.J. N-methyl-d-aspartate receptors: subunit assembly and trafficking to the synapse. J Biol Chem 279 11 (2004) 9673-9676
63. Fukaya M., Kato A., Lovett C., Tonegawa S., and Watanabe M. Retention of NMDA receptor NR2 subunits in the lumen of endoplasmic reticulum in targeted NR1 knockout mice. Proc Natl Acad Sci USA 100 8 (2003) 4855-4860
64. van Zundert B., Yoshii A., and Constantine-Paton M. Receptor compartmentalization and trafficking at glutamate synapses: a developmental proposal. Trends Neurosci 27 7 (2004) 428-437
65. Mok H., Shin H., Kim S., Lee J.R., Yoon J., and Kim E. Association of the kinesin superfamily motor protein KIF1Balpha with postsynaptic density-95 (PSD-95), synapse-associated protein-97, and synaptic scaffolding molecule PSD-95/discs large/zona occludens-1 proteins. J Neurosci 22 13 (2002) 5253-5258
66. Guillaud L., Setou M., and Hirokawa N. KIF17 dynamics and regulation of NR2B trafficking in hippocampal neurons. J Neurosci 23 1 (2003) 131-140
67. Zeron M.M., Hansson O., Chen N., Wellington C.L., Leavitt B.R., Brundin P., et al. Increased sensitivity to N-methyl-d-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease. Neuron 33 6 (2002) 849-860
68. Fong D.K., Rao A., Crump F.T., and Craig A.M. Rapid synaptic remodeling by protein kinase C: reciprocal translocation of NMDA receptors and calcium/calmodulin-dependent kinase II. J Neurosci 22 6 (2002) 2153-2164
69. Prybylowski K., Chang K., Sans N., Kan L., Vicini S., and Wenthold R.J. The synaptic localization of NR2B-containing NMDA receptors is controlled by interactions with PDZ proteins and AP-2. Neuron 47 6 (2005) 845-857
70. Fuller P.I., Reddrop C., Rodger J., Bellingham M.C., and Phillips J.K. Differential expression of the NMDA NR2B receptor subunit in motoneuron populations susceptible and resistant to amyotrophic lateral sclerosis. Neurosci Lett 399 1-2 (2006) 157-161
71. Harris A, Petitt DL. The role of extrasynaptic NMDA receptors in plasticity. Society for Neuroscience, November 2007 abstract.
72. Kutsuwada T., Sakimura K., Manabe T., Takayama C., Katakura N., Kushiya E., et al. Impairment of suckling response, trigeminal neuronal pattern formation, and hippocampal LTD in NMDA receptor epsilon 2 subunit mutant mice. Neuron 16 2 (1996) 333-344
73. Lim I.A., Hall D.D., and Hell J.W. Selectivity and promiscuity of the first and second PDZ domains of PSD-95 and synapse-associated protein 102. J Biol Chem 277 24 (2002) 21697-21711
74. Lee H.K. Synaptic plasticity and phosphorylation. Pharmacol Ther 112 3 (2006) 810-832
75. Bayer K.U., De Koninck P., Leonard A.S., Hell J.W., and Schulman H. Interaction with the NMDA receptor locks CaMKII in an active conformation. Nature 411 6839 (2001) 801-805
76. Lisman J., Schulman H., and Cline H. The molecular basis of CaMKII function in synaptic and behavioural memory. Nat Rev Neurosci 3 3 (2002) 175-190
77. Das S., Sasaki Y.F., Rothe T., Premkumar L.S., Takasu M., Crandall J.E., et al. Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A. Nature 393 6683 (1998) 377-381
78. Perez-Otano I., Schulteis C.T., Contractor A., Lipton S.A., Trimmer J.S., Sucher N.J., et al. Assembly with the NR1 subunit is required for surface expression of NR3A-containing NMDA receptors. J Neurosci 21 4 (2001) 1228-1237
79. Wada A., Takahashi H., Lipton S.A., and Chen H.S. NR3A modulates the outer vestibule of the "NMDA" receptor channel. J Neurosci 26 51 (2006) 13156-13166
80. Cavara NA, Hollman M. NR3 differentially influences NMDAR function. SfN Abstract, November 2007.
81. Chatterton J.E., Awobuluyi M., Premkumar L.S., Takahashi H., Talantova M., Shin Y., et al. Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature 415 6873 (2002) 793-798
82. Pina-Crespo J.C., and Heinemann S.F. Physiological and pharmacological properties of recombinant NR3-type receptors expressed in mammalian cells. Soc Neurosci Abstr 30 (2004) 957.1
83. Matsuda K., Fletcher M., Kamiya Y., and Yuzaki M. Specific assembly with the NMDA receptor 3B subunit controls surface expression and calcium permeability of NMDA receptors. J Neurosci 23 31 (2003) 10064-10073
84. Boeckman F.A., and Aizenman E. Stable transfection of the NR1 subunit in Chinese hamster ovary cells fails to produce a functional N-methyl-d-aspartate receptor. Neurosci Lett 173 12 (1994) 189-192
85. Kuryatov A., Laube B., Betz H., and Kuhse J. Mutational analysis of the glycine-binding site of the NMDA receptor: structural similarity with bacterial amino acid-binding proteins. Neuron 12 6 (1994) 1291-1300
86. Laube B., Kuhse J., and Betz H. Evidence for a tetrameric structure of recombinant NMDA receptors. J Neurosci 18 8 (1998) 2954-2961
87. Priestley T. Pharmacology and electrophysiology of excitatory amino acid receptors. In: Sirinathsinghji D.J.S., and Hill R.G. (Eds). NMDA antagonists as potential analgesic drugs (2002), Birkhauser, Basel 5-44
88. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1 8 (1988) 623-634
89. Wang C.X., and Shuaib A. NMDA/NR2B selective antagonists in the treatment of ischemic brain injury. Curr Drug Targets CNS Neurol Disord 4 2 (2005) 143-151
90. Kemp J.A., Foster A.C., and Wong E.H. Non-competitive antagonists of excitatory amino acid receptors. Trends Neurosci 10 (1987) 294
91. Bennett D.A., Lehmann J., Bernard P.S., Liebman J.M., Williams M., Wood P.L., et al. CGS 19755: a novel competitive N-methyl-d-aspartate (NMDA) receptor antagonist with anticonvulsant, anxiolytic and anti-ischemic properties. Prog Clin Biol Res 361 (1990) 519-524
92. Murphy D.E., Hutchison A.J., Hurt S.D., Williams M., and Sills M.A. Characterization of the binding of [3H]-CGS 19755: a novel N-methyl-d-aspartate antagonist with nanomolar affinity in rat brain. Br J Pharmacol 95 3 (1988) 932-938
93. Leeson P.D., and Iversen L.L. The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential. J Med Chem 37 24 (1994) 4053-4067
94. Williams K. Ifenprodil, a novel NMDA receptor antagonist: site and mechanism of action. Curr Drug Targets 2 3 (2001) 285-298
95. McCauley J.A. NR2B subtype-selective NMDA receptor antagonists: 2001-2004. Expert Opin Ther Patents 15 4 (2005) 389-407
96. Boyce S., Wyatt A., Webb J.K., O'Donnell R., Mason G., Rigby M., et al. Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn. Neuropharmacology 38 5 (1999) 611-623
97. Carter C., Benavides J., Legendre P., Vincent J.D., Noel F., Thuret F., et al. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-d-aspartate receptor antagonist properties. J Pharmacol Exp Ther 247 3 (1988) 1222-1232
98. Williams K. Ifenprodil discriminates subtypes of the N-methyl-d-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Mol Pharmacol 44 4 (1993) 851-859
99. Kew J.N., Trube G., and Kemp J.A. A novel mechanism of activity-dependent NMDA receptor antagonism describes the effect of ifenprodil in rat cultured cortical neurones. J Physiol 497 Pt 3 (1996) 761-772
100. Grimwood S., Richards P., Murray F., Harrison N., Wingrove P.B., and Hutson P.H. Characterisation of N-methyl-d-aspartate receptor-specific [(3)H]Ifenprodil binding to recombinant human NR1a/NR2B receptors compared with native receptors in rodent brain membranes. J Neurochem 75 6 (2000) 2455-2463
101. Perin-Dureau F., Rachline J., Neyton J., and Paoletti P. Mapping the binding site of the neuroprotectant ifenprodil on NMDA receptors. J Neurosci 22 14 (2002) 5955-5965
102. Chenard B.L., Bordner J., Butler T.W., Chambers L.K., Collins M.A., De Costa D.L., et al. (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: a potent new neuroprotectant which blocks N-methyl-d-aspartate responses. J Med Chem 38 16 (1995) 3138-3145
103. Lynch D.R., and Guttmann R.P. NMDA receptor pharmacology: perspectives from molecular biology. Curr Drug Targets 2 3 (2001) 215-231
104. Menniti F., Chenard B., Collins M., Ducat M., Shalaby I., and White F. CP-101,606, a potent neuroprotectant selective for forebrain neurons. Eur J Pharmacol 331 2-3 (1997) 117-126
105. Fischer G., Mutel V., Trube G., Malherbe P., Kew J.N., Mohacsi E., et al. Ro 25-6981, a highly potent and selective blocker of N-methyl-d-aspartate receptors containing the NR2B subunit. Characterization in vitro. J Pharmacol Exp Ther 283 3 (1997) 1285-1292
106. Chazot P.L., Lawrence S., and Thompson C.L. Studies on the subtype selectivity of CP-101,606: evidence for two classes of NR2B-selective NMDA receptor antagonists. Neuropharmacology 42 3 (2002) 319-324
107. Minami T., Matsumura S., Okuda-Ashitaka E., Shimamoto K., Sakimura K., Mishina M., et al. Characterization of the glutamatergic system for induction and maintenance of allodynia. Brain Res 895 1-2 (2001) 178-185
108. Taniguchi K., Shinjo K., Mizutani M., Shimada K., Ishikawa T., Menniti F.S., et al. Antinociceptive activity of CP-101,606, an NMDA receptor NR2B subunit antagonist. Br J Pharmacol 122 5 (1997) 809-812
109. Sang C.N., Weaver J.J., Jinga L., Woulden J., and Saltarelli M.D. The NR2B subunit-selective NMDA receptor antagonist, CP-101,606, reduces spontaneous pain intensity in patients with central and peripheral neuropathic pain. Abstr Soc Neurosci Washington 2003 (2003) 814.9
110. Merchant R.E., Bullock M.R., Carmack C.A., Shah A.K., Wilner K.D., Ko G., et al. A double-blind, placebo-controlled study of the safety, tolerability and pharmacokinetics of CP-101,606 in patients with a mild or moderate traumatic brain injury. Ann NY Acad Sci 890 (1999) 42-50
111. Bullock M.R., Merchant R.E., Carmack C.A., Doppenberg E., Shah A.K., Wilner K.D., et al. An open-label study of CP-101,606 in subjects with a severe traumatic head injury or spontaneous intracerebral hemorrhage. Ann NY Acad Sci 890 (1999) 51-58
112. Chizh B.A., Headley P.M., and Tzschentke T.M. NMDA receptor antagonists as analgesics: focus on the NR2B subtype. Trends Pharmacol Sci 22 12 (2001) 636-642
113. Arundine M., and Tymianski M. Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. Cell Calcium 34 4-5 (2003) 325-337
114. Sattler R., and Tymianski M. Molecular mechanisms of calcium-dependent excitotoxicity. J Mol Med 78 1 (2000) 3-13
115. Aarts M.M., and Tymianski M. Novel treatment of excitotoxicity: targeted disruption of intracellular signalling from glutamate receptors. Biochem Pharmacol 66 6 (2003) 877-886
116. Li L., Fan M., Icton C.D., Chen N., Leavitt B.R., Hayden M.R., et al. Role of NR2B-type NMDA receptors in selective neurodegeneration in Huntington disease. Neurobiol Aging 24 8 (2003) 1113-1121
117. Chen N., Luo T., Wellington C., Metzler M., McCutcheon K., Hayden M.R., et al. Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin. J Neurochem 72 5 (1999) 1890-1898
118. Zeron M.M., Chen N., Moshaver A., Lee A.T., Wellington C.L., Hayden M.R., et al. Mutant huntingtin enhances excitotoxic cell death. Mol Cell Neurosci 17 1 (2001) 41-53
119. Arning L., Saft C., Wieczorek S., Andrich J., Kraus P.H., and Epplen J.T. NR2A and NR2B receptor gene variations modify age at onset in Huntington disease in a sex-specific manner. Hum Genet 122 2 (2007) 175-182
120. Stefani M.R., and Moghaddam B. Transient N-methyl-d-aspartate receptor blockade in early development causes lasting cognitive deficits relevant to schizophrenia. Biol Psychiat 57 4 (2005) 433-436
121. Heresco-Levy U., and Javitt D.C. The role of N-methyl-d-aspartate (NMDA) receptor-mediated neurotransmission in the pathophysiology and therapeutics of psychiatric syndromes. Eur Neuropsychopharmacol 8 2 (1998) 141-152
122. Gao X.M., Sakai K., Roberts R.C., Conley R.R., Dean B., and Tamminga C.A. Ionotropic glutamate receptors and expression of N-methyl-d-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. Am J Psychiat 157 7 (2000) 1141-1149
123. du Bois T.M., and Huang X.F. Early brain development disruption from NMDA receptor hypofunction: relevance to schizophrenia. Brain Res Rev 53 2 (2007) 260-270
124. Grimwood S., Slater P., Deakin J.F., and Hutson P.H. NR2B-containing NMDA receptors are up-regulated in temporal cortex in schizophrenia. Neuroreport 10 3 (1999) 461-465
125. Mueller H.T., and Meador-Woodruff J.H. NR3A NMDA receptor subunit mRNA expression in schizophrenia, depression and bipolar disorder. Schizophr Res 71 2-3 (2004) 361-370
126. Ułas J., Weihmuller F.B., Brunner L.C., Joyce J.N., Marshall J.F., and Cotman C.W. Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson's disease, Alzheimer's disease, and mixed Parkinson's disease/Alzheimer's disease patients: an autoradiographic study. J Neurosci 14 11 Pt 1 (1994) 6317-6324
127. Albin R.L., Young A.B., and Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci 12 10 (1989) 366-375
128. Löschmann P.A., De Groote C., Smith L., Wüllner U., Fischer G., Kemp J.A., et al. Antiparkinsonian activity of Ro 25-6981, a NR2B subunit specific NMDA receptor antagonist, in animal models of Parkinson's disease. Exp Neurol 187 1 (2004) 86-93
129. Hallett P.J., and Standaert D.G. Rationale for and use of NMDA receptor antagonists in Parkinson's disease. Pharmacol Ther 102 2 (2004) 155-174
130. Wessell R.H., Ahmed S.M., Menniti F.S., Dunbar G.L., Chase T.N., and Oh J.D. NR2B selective NMDA receptor antagonist CP-101,606 prevents levodopa-induced motor response alterations in hemi-parkinsonian rats. Neuropharmacology 47 2 (2004) 184-194
131. Albensi B.C., Igoechi C., Janigro D., and Ilkanich E. Why do many NMDA antagonists fail, while others are safe and effective at blocking excitotoxicity associated with dementia and acute injury?. Am J Alzheimers Dis Other Demen 19 5 (2004) 269-274
132. Doraiswamy P.M. Alzheimer's disease and the glutamate NMDA receptor. Psychopharmacol Bull 37 2 (2003) 41-49
133. Lipton S.A. Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation. Curr Drug Targets 8 5 (2007) 621-632
134. Samarasinghe S., Virgo L., and de Belleroche J. Distribution of the N-methyl-d-aspartate glutamate receptor subunit NR2A in control and amyotrophic lateral sclerosis spinal cord. Brain Res 727 1-2 (1996) 233-237
135. Shaw P.J., Ince P.G., Matthews J.N., Johnson M., and Candy J.M. N-methyl-d-aspartate (NMDA) receptors in the spinal cord and motor cortex in motor neuron disease: a quantitative autoradiographic study using [3H]MK-801. Brain Res 637 1-2 (1994) 297-302
136. Gorman A.M., McGowan A., O'Neill C., and Cotter T. Oxidative stress and apoptosis in neurodegeneration. J Neurol Sci 139 Suppl. (1996) 45-52
137. Rao S.D., and Weiss J.H. Excitotoxic and oxidative cross-talk between motor neurons and glia in ALS pathogenesis. Trends Neurosci 27 1 (2004) 17-23
138. Siesjö B.K., Zhao Q., Pahlmark K., Siesjö P., Katsura K., and Folbergrová J. Glutamate, calcium, and free radicals as mediators of ischemic brain damage. Ann Thorac Surg 59 5 (1995) 1316-1320
139. Virgo L., and de Belleroche J. Induction of the immediate early gene c-jun in human spinal cord in amyotrophic lateral sclerosis with concomitant loss of NMDA receptor NR-1 and glycine transporter mRNA. Brain Res 676 1 (1995) 196-204
140. Allaoua H., Chaudieu I., Boksa P., Perry T.L., Krieger C., and Quirion R. Excitatory amino acid receptors in human spinal cord. Evaluation in amyotrophic lateral sclerosis patients. Ann NY Acad Sci 648 (1992) 260-262
141. Niemann S., Kanki H., Fukui Y., Takao K., Fukaya M., Hynynen M.N., et al. Genetic ablation of NMDA receptor subunit NR3B in mouse reveals motoneuronal and nonmotoneuronal phenotypes. Eur J Neurosci 26 6 (2007) 1407-1420
142. Wang R., and Zhang D. Memantine prolongs survival in an amyotrophic lateral sclerosis mouse model. Eur J Neurosci 22 9 (2005) 2376-2380
143. Markenson J.A. Mechanisms of chronic pain. Am J Med 101 1A (1996) 6S-18S
144. Petrenko A.B., Yamakura T., Baba H., and Shimoji K. The role of N-methyl-d-aspartate (NMDA) receptors in pain: a review. Anesth Analg 97 4 (2003) 1108-1116
145. Chizh B.A. Novel approaches to targeting glutamate receptors for the treatment of chronic pain: review article. Amino Acids 23 1-3 (2002) 169-176
146. Kemp J.A., and McKernan R.M. NMDA receptor pathways as drug targets. Nat Neurosci 5 Suppl. (2002) 1039-1042
147. Haley J.E., Sullivan A.F., and Dickenson A.H. Evidence for spinal N-methyl-d-aspartate receptor involvement in prolonged chemical nociception in the rat. Brain Res 518 1-2 (1990) 218-226
148. Ma Q.P., and Woolf C.J. The NMDA receptor, pain and central sensitization. In: Sirinathsinghji D.J.S., and Hill R.G. (Eds). NMDA antagonists as potential analgesic drugs (2002), Birkhauser, Basel 83-103
149. Zhuo M. Glutamate receptors and persistent pain: targeting forebrain NR2B subunits. Drug Discov Today 7 4 (2002) 259-267
150. Woolf C.J. Evidence for a central component of post-injury pain hypersensitivity. Nature 306 5944 (1983) 686-688
151. Cook A.J., Woolf C.J., Wall P.D., and McMahon S.B. Dynamic receptive field plasticity in rat spinal cord dorsal horn following C-primary afferent input. Nature 325 7000 (1987) 151-153
152. Medvedev I.O., Malyshkin A.A., Belozertseva I.V., Sukhotina I.A., Sevostianova N.Y., Aliev K., et al. Effects of low-affinity NMDA receptor channel blockers in two rat models of chronic pain. Neuropharmacology 47 2 (2004) 175-183
153. Bliss T.V., and Lomo T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol 232 2 (1973) 331-356
154. Ultenius C., Linderoth B., Meyerson B.A., and Wallin J. Spinal NMDA receptor phosphorylation correlates with the presence of neuropathic signs following peripheral nerve injury in the rat. Neurosci Lett 399 1-2 (2006) 85-90
155. Zheng X., Zhang L., Wang A.P., Bennett M.V., and Zukin R.S. Ca2+ influx amplifies protein kinase C potentiation of recombinant NMDA receptors. J Neurosci 17 22 (1997) 8676-8686
156. Davies S.N., and Lodge D. Evidence for involvement of N-methylaspartate receptors in 'wind-up' of class 2 neurones in the dorsal horn of the rat. Brain Res 424 2 (1987) 402-406
157. Dickenson A.H., and Sullivan A.F. Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C fibre stimulation. Neuropharmacology 26 8 (1987) 1235-1238
158. Massey P.V., Johnson B.E., Moult P.R., Auberson Y.P., Brown M.W., Molnar E., et al. Differential roles of NR2A and NR2B-containing NMDA receptors in cortical long-term potentiation and long-term depression. J Neurosci 24 36 (2004) 7821-7828
159. O'Donnell R., Molon-Noblot S., Laroque P., Rigby M., and Smith D. The ultrastructural localisation of the N-methyl-d-aspartate NR2B receptor subunit in rat lumbar spinal cord. Neurosci Lett 371 1 (2004) 24-29
160. Mutel V., Buchy D., Klingelschmidt A., Messer J., Bleuel Z., Kemp J.A., et al. In vitro binding properties in rat brain of [3H]Ro 25-6981, a potent and selective antagonist of NMDA receptors containing NR2B subunits. J Neurochem 70 5 (1998) 2147-2155
161. Ma Q.P., and Hargreaves R.J. Localization of N-methyl-d-aspartate NR2B subunits on primary sensory neurons that give rise to small-caliber sciatic nerve fibers in rats. Neuroscience 101 3 (2000) 699-707
162. Wei F., Wang G.D., Kerchner G.A., Kim S.J., Xu H.M., Chen Z.F., et al. Genetic enhancement of inflammatory pain by forebrain NR2B overexpression. Nat Neurosci 4 2 (2001) 164-169
163. Rosenblum K., Dudai Y., and Richter-Levin G. Long-term potentiation increases tyrosine phosphorylation of the N-methyl-d-aspartate receptor subunit 2B in rat dentate gyrus in vivo. Proc Natl Acad Sci USA 93 19 (1996) 10457-10460
164. Rostas J.A., Brent V.A., Voss K., Errington M.L., Bliss T.V., and Gurd J.W. Enhanced tyrosine phosphorylation of the 2B subunit of the N-methyl-d-aspartate receptor in long-term potentiation. Proc Natl Acad Sci USA 93 19 (1996) 10452-10456
165. Lee H.K. Synaptic plasticity and phosphorylation. Pharmacol Ther 112 3 (2006) 810-832
166. Abe T., Matsumura S., Katano T., Mabuchi T., Takagi K., Xu L., et al. Fyn kinase-mediated phosphorylation of NMDA receptor NR2B subunit at Tyr1472 is essential for maintenance of neuropathic pain. Eur J Neurosci 22 6 (2005) 1445-1454
167. Levine E.S., and Kolb J.E. Brain-derived neurotrophic factor increases activity of NR2B-containing N-methyl-d-aspartate receptors in excised patches from hippocampal neurons. J Neurosci Res 62 3 (2000) 357-362